Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Pennsylvania for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Pennsylvania only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Pennsylvania (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Robert Singh (NPI 1154447175)

Field	Value
Entity Type	Individual
Organization	Robert Singh
Address	1900 Market St
City	Philadelphia
State	PA
ZIP	19103
Taxonomy	Vascular Surgery Physician
NPI Enumerated	March 21, 2007

Payer Source	Total Paid
Medicare	$5.7M
Medicaid	$0

Key Findings

This provider’s recorded revenue is effectively single-payer: total Medicare revenue is $5.7M and there is no Medicaid billing on file. The NPI was enumerated 2007-03-21 (~19 years ago), indicating nearly two decades of enrollment during which Medicare has been the dominant source of billed revenue for this entity.

Revenue concentration is high: the precomputed top three Medicare codes by revenue account for 48.8% of the provider’s total Medicare revenue. Those top three codes are J3245 (21.2%), J0256 (14.3%), and J1306 (13.4%), showing nearly half of Medicare dollars come from a very small set of biologic drug codes.

The code mix and descriptions point to a practice model centered on high-cost biologic injectables and infusion administration rather than typical vascular-procedure billing. High-revenue line items include branded biologic injections such as J3245 (tildrakizumab), J1306 (inclisiran), and J0256 (alpha 1 proteinase inhibitor), alongside infusion/administration procedure codes like 96365 and 96372, indicating routine in-office or clinic-based infusion services.

This provider occupies a nationally prominent position on several specific drug codes: J0256 ranks #1 of 12 providers nationally (100th percentile), J1306 ranks #7 of 462 providers (99th percentile), J0517 ranks #2 of 200 providers (99th percentile), and J3245 ranks #11 of 225 providers (96th percentile). Those rank/percentile placements identify the provider as a major national-volume participant for multiple high-revenue biologic injectables.

Multiple codes are flagged as unusually high-volume versus peers: J1306 and J0517 are labeled “extreme outlier, far above typical national volume,” and J0256 and J3245 are described as “notably above typical national volume.” Additionally, 96372 is a 100th-percentile extreme outlier for injection administration volume. These descriptors indicate volumes that exceed typical national practice patterns for those services.

Claim counts underline substantial operational throughput for infusion/injectable care: J0256 shows 202.8K claims, J1306 shows 84.6K claims, and J3245 shows 11.7K claims as reported. Such high claim volumes are consistent with a high-frequency infusion or biologics administration operation and suggest established workflows and capacity for frequent drug administration.

From a payer-contracting and utilization perspective, nearly half of Medicare revenue coming from a small set of biologic drugs (48.8% from the top three codes) combined with no Medicaid revenue means the provider’s financial profile is concentrated and Medicare-dependent. That concentration could make revenue sensitive to changes in Medicare coverage, reimbursement, or utilization management for those specific drugs.

There is a notable taxonomy-to-billing signal to investigate: the provider is registered as a Vascular Surgery Physician but the billing footprint is dominated by biologic drug injections and infusion administration codes. This divergence suggests the provider may be operating an infusion/biologics service line under that NPI or otherwise billing high volumes of injectable/infusible therapies, and merits follow-up if specialty alignment or credentialing is a concern.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3245	Injection, tildrakizumab, 1 mg	11,700	$100	$1.2M
J0256	Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg	202,810	$1	$811.3K
J1306	Injection, inclisiran, 1 mg	84,630	$10	$761.7K
J0517	Injection, benralizumab, 1 mg	5,400	$130	$702.1K
J2357	Injection, omalizumab, 5 mg	20,550	$30	$616.5K
J2356	Injection, tezepelumab-ekko, 1 mg	31,920	$10	$446.9K
J2182	Injection, mepolizumab, 1 mg	15,400	$20	$354.2K
J2350	Injection, ocrelizumab, 1 mg	8,100	$40	$348.3K
J3380	Injection, vedolizumab, intravenous, 1 mg	15,600	$20	$265.2K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	860	$50	$46.6K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Pennsylvania Distribution

Robert Singh — 8 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Pennsylvania

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	3	10	3,750	$110	$670.1K
J0256	1	10	60,840	$1	$395.7K
J2350	1	10	7,650	$50	$346.4K
J0517	1	10	1,560	$130	$276.6K
J2357	2	30	6,810	$30	$239.4K
J2182	2	10	4,550	$20	$172.9K
J2356	1	10	7,770	$10	$166.7K
J1306	1	20	8,800	$10	$155K
J3380	4	40	5,550	$20	$130.4K
J1745	53	80	3,630	$30	$115.4K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Robert Singh, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Emma Singh	PA	Family Medicine Physician	$1.5M	$0
Mariem Abedullah	NJ	Family Nurse Practitioner	$672.2K	$0
Jeeness Macatangay	NY	Adult Health Nurse Practitioner	$274.7K	$0
Michelle Levins	NY	Registered Nurse	$70.4K	$5.2K

Nearby Providers

Other providers in the same ZIP code as Robert Singh, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Medscope America LLC	PA	Emergency Response System Companies	$0	$65.2M
Daily Dove Care, LLC	PA	Home Health Agency	$0	$42M
Bayada Home Health Care, Inc.	PA	Home Health Agency	$0	$22.4M
Allborogh Personal Care Inc.	PA	In Home Supportive Care Agency	$0	$11M
Alexander Ehrlich	PA	Dermatology Physician	$275K	$0
David Kalkstein	PA	Psychiatry Physician	$235K	$0
Neuro Dynamics Penn	PA	Portable X-ray and/or Other Portable Diagnostic Imaging Supplier	$199.4K	$0
Pennsylvania Cvs Pharmacy, L.L.C.	PA	Pharmacy	$183.8K	$0
Dana Amiraian	PA	Diagnostic Radiology Physician	$168.9K	$0
David Rose	PA	Podiatrist	$99.8K	$48.1K

Robert Singh — Billing Profile & Reimbursement Data

Sign up for Robert Singh — Billing Profile & Reimbursement Data policy alerts

Robert Singh — Billing Profile & Reimbursement Data

Sign up for Robert Singh — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References